According to Ouyang et al. (2022), miR-1298 overexpression reduces cardiomyocyte apoptosis in ischemia-reperfusion injury of the heart by inhibiting apoptosis (decreased BAX expression and increased Bcl-2 expression) and AMPK signalling activation. The gene discussed is BCL2; the disease is ischemia reperfusion injury.